Risk factors for parkinson’s disease: The leisure world cohort study
Abstract
We conducted a case-control study nested within a prospective cohort study of 13,979 residents of Leisure World Laguna Hills, a retirement community in southern California, for etiologic clues for Parkinson's disease (PD). Between 1981 (when first mailed a health survey) and 1998, we identified 395 PD cases from death certificates, hospital discharge diagnoses and a 1992 follow-up questionnaire. Six controls were individually matched on sex, birth date (+/-2 years), vital status and, if dead, death date (+/-1 year) to each case. Baseline characteristics of the 395 cases and 2,320 controls were analyzed as potential PD risk factors. The risk of PD was significantly reduced among smokers, hypertensives, coffee drinkers and alcohol consumers, and significantly increased among those with 3 or more children and with a high intake of total vitamin A and dietary vitamin C. The multivariate odds ratios (95% confidence intervals) were 0.42 (0.22-0.80) for current cigarette smokers of 1+ pack/day, 0.62 (0.48-0.80) for current users of hypertensive medication, 0.71 (0.52-0.95) for coffee drinkers of 2+ cups/day and 0.77 (0.58-1.03) for drinkers of 2+ alcoholic drinks/day. Risk increased with increasing number of children (1.25 for 1, 1.34 for 2 and 1.90 for 3+ children; p for trend = 0.0003). The increased risks among individuals in the highest third of total vitamin A intake and of dietary vitamin C intake were no longer statistically significant after adjusting for the other variables. These findings suggest several environmental factors that may be related to the development of PD and support a multifactorial etiology.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
An inverse association between coffee consumption and PD risk has been found in several epidemiological studies.
“An inverse association between coffee consumption and PD risk has been found in several epidemiological studies [110,121,122,123].”
From Effect of Caffeine Consumption on the Risk for Neurological and Psychiatric Disorders: Sex Differences in Human (2020) · cites this paper as [121]
Cites
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378 · see citing works
Statistical Methods in Cancer Research
Breslow, N. E. (1980) · Cited by 7,332 · see citing works
Statistical methods in cancer research. Volume I - The analysis of case-control studies.
Breslow, N. E., & Day, N. E. (1980) · PubMed · Cited by 4,895 · see citing works
Nehlig, A., Daval, J., & Debry, G. (1992) · Brain Research Reviews · doi:10.1016/0165-0173(92)90012-b · Cited by 1,463 · see citing works
The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it
Fahn, S., & Cohen, G. (1992) · Annals of Neurology · doi:10.1002/ana.410320616 · Cited by 927 · see citing works
de Rijk, M. C., Tzourio, C., Breteler, M. M., Dartigues, J. F., Amaducci, L., Lopez-Pousa, S., Manubens-Bertran, J. M., Alperovitch, A., & Rocca, W. A. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.1.10 · Cited by 833 · see citing works
Environmental risk factors and Parkinson's disease
Liou, H., Tsai, M.-C., Chen, C., Jeng, J., Chang, Y. C., Chen, S. Y., & Chen, R.-T. (1997) · Neurology · doi:10.1212/wnl.48.6.1583 · Cited by 616 · see citing works
NUTRIENT SOURCES IN THE AMERICAN DIET: QUANTITATIVE DATA FROM THE NHANES II SURVEY
Block, G., DRESSER, C. M., Hartman, A. M., & Carroll, M. D. (1985) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114072 · Cited by 511 · see citing works
Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990
Bower, J. H., Maraganore, D. M., McDonnell, S. K., & Rocca, W. A. (1999) · Neurology · doi:10.1212/wnl.52.6.1214 · Cited by 509 · see citing works
Prevalence of Parkinson's disease in the elderly
de Rijk, M. C., Breteler, M. M. B., Graveland, G. A., Ott, A., Grobbee, D. E., van der Meché, F. G. A., & Albert Hofman, D. (1995) · Neurology · doi:10.1212/wnl.45.12.2143 · Cited by 488 · see citing works
Mayeux, R. P., Marder, K. S., COTE, L. J., Denaro, J. E., Hemenegildo, N., Mejia‐Santana, H., Tang, M., Lantigua, R., Wilder, D., Gurland, B. J., et al. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117721 · Cited by 387 · see citing works
Cigarette smoking and protection from Parkinson's disease
Morens, D. M., Grandinetti, A., REED, D. M., White, L. R., & Ross, G. W. (1995) · Neurology · doi:10.1212/wnl.45.6.1041 · Cited by 368 · see citing works
Worldwide Occurrence of Parkinson's Disease: An Updated Review
Zhang, Z., & Román, G. C. (1993) · Neuroepidemiology · doi:10.1159/000110318 · Cited by 332 · see citing works
RELIABILITY OF RECALL OF DRUG USAGE AND OTHER HEALTH-RELATED INFORMATION1
Paganini‐Hill, A., & Ross, R. (1982) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113386 · Cited by 320 · see citing works
Self-citationNew insights into the cause of Parkinson's disease
Jenner, P., Schapira, A. H. V., & MARSDEN, C. D. (1992) · Neurology · doi:10.1212/wnl.42.12.2241 · Cited by 272 · see citing works
Smoking and Parkinson’s disease
Gorell, J. M., Rybicki, B. A., Johnson, C. C., & Peterson, E. L. (1999) · Neurology · doi:10.1212/wnl.52.1.115 · Cited by 224 · see citing works
Prospective Study of Cigarette Smoking and the Risk of Developing Idiopathic Parkinson's Disease
Grandinetti, A., Morens, D. M., REED, D. M., & MacEachern, D. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116960 · Cited by 221 · see citing works
Diet and Parkinson's disease II
Hellenbrand, W., Boeing, H., Robra, B., Seidler, A., Vieregge, P., NISCHAN, P., Joerg, J., Oertel, W. H., Schneider, E., & Ulm, G. (1996) · Neurology · doi:10.1212/wnl.47.3.644 · Cited by 195 · see citing works
Epidemiologic study of Parkinson's disease in Hong Kong
Ho, S. C., Woo, J., & Lee, C. M. (1989) · Neurology · doi:10.1212/wnl.39.10.1314 · Cited by 172 · see citing works
Epidemiology versus genetics in parkinson's disease: Progress in resolving an age‐old debate
Langston, J. W. (1998) · Annals of Neurology · doi:10.1002/ana.410440707 · Cited by 165 · see citing works
Woodward, J. J., & Gonzales, R. A. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb01931.x · Cited by 165 · see citing works
Risk-factors for Parkinson's disease: case-control study in the province of Cáceres, Spain
Morano, A. E., Jiménez‐Jiménez, F. J., Pérez-Molina, J. A., & Antolín, M. A. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1994.tb01655.x · Cited by 150 · see citing works
Paganini‐Hill, A., & Chao, A. (1993) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116832 · Cited by 140 · see citing works
Self-citationChanging epidemiology of Parkinson’s disease in southwestern Finland
Kuopio, A., Marttila, R. J., Helenius, H. Y. M., & Rinne, U. K. (1999) · Neurology · doi:10.1212/wnl.52.2.302 · Cited by 137 · see citing works
Cause-specific mortality: understanding uncertain tips of the disease iceberg.
Goldacre, M. J. (1993) · Journal of Epidemiology & Community Health · doi:10.1136/jech.47.6.491 · Cited by 129 · see citing works
The Epidemiology of Parkinson’s Disease in an Australian Population
McCann, S. J., Couteur, D. G. L., Green, A. C., Brayne, C., Johnson, A. G., Chan, D., McManus, M. E., & Pond, S. M. (1998) · Neuroepidemiology · doi:10.1159/000026185 · Cited by 124 · see citing works
Epidemiologic Approaches to the Study of Parkinsonʼs Disease Etiology
Checkoway, H., & Nelson, L. M. (1999) · Epidemiology · doi:10.1097/00001648-199905000-00023 · Cited by 122 · see citing works
Diet and Parkinson's disease I
Hellenbrand, W., Seidler, A., Boeing, H., Robra, B., Vieregge, P., NISCHAN, P., Joerg, J., Oertel, W. H., Schneider, E., & Ulm, G. (1996) · Neurology · doi:10.1212/wnl.47.3.636 · Cited by 119 · see citing works
Case-Control Study of Early Life Dietary Factors in Parkinson's Disease
Golbe, L. I., Farrell, T. M., & Davis, P. H. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520360068014 · Cited by 115 · see citing works
Follow‐up study of early‐life protective and risk factors in Parkinson's disease
Golbe, L. I., Farrell, T. M., & Davis, P. H. (1990) · Movement Disorders · doi:10.1002/mds.870050116 · Cited by 113 · see citing works
Jiméanez‐Jiméanez, F. J., Mateo, D., & Giméanez‐Roldan, S. (1992) · Movement Disorders · doi:10.1002/mds.870070407 · Cited by 102 · see citing works
Age-standardized incidence and prevalence of Parkinson's disease in a Swedish community
Fall, P.-A., Axelson, O., Fredriksson, M. G., Hansson, G., Lindvall, B., Olsson, J., & Granérus, A. (1996) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(96)00003-0 · Cited by 101 · see citing works
Thrift, A. G., Donnan, G. A., & McNeil, J. J. (1999) · Epidemiology · doi:10.1097/00001648-199905000-00020 · Cited by 100 · see citing works
Dietary antioxidants and other dietary factors in the etiology of Parkinson's disease
Scheider, W. L., Hershey, L. A., Vena, J. E., Holmlund, T., Marshall, J. R., & Freudenheim, J. L. (1997) · Movement Disorders · doi:10.1002/mds.870120209 · Cited by 98 · see citing works
Alcohol and central neurotransmission
Ollat, H., Parvez, H. S., & Parvez, S. (1988) · Neurochemistry International · doi:10.1016/0197-0186(88)90001-0 · Cited by 96 · see citing works
Case‐control study of idiopathic Parkinson's disease and dietary vitamin E intake
Morens, D. M., Grandinetti, A., Waslien, C., Park, C. B., Ross, G. W., & White, L. R. (1996) · Neurology · doi:10.1212/wnl.46.5.1270 · Cited by 91 · see citing works
Smoking and Parkinson's disease: a case-control study in Germany
Hellenbrand, W., Seidler, A., Robra, B., Vieregge, P., Oertel, W. H., Joerg, J., NISCHAN, P., Schneider, E., & Ulm, G. (1997) · International Journal of Epidemiology · doi:10.1093/ije/26.2.328 · Cited by 87 · see citing works
A Case-Control Study on the Environmental Risk Factors of Parkinson's Disease in Tianjin, China
Wang, W., Fang, X., Cheng, X.-M., Jiang, D., & Lin, Z.-J. (1993) · Neuroepidemiology · doi:10.1159/000110319 · Cited by 70 · see citing works
Smoking and Parkinson's disease
Tzourio, C., Rocca, W. A., Breteler, M. M. B., Baldereschi, M., Dartigues, J.-F., Pousa, S. L., Manubens-Bertran, J. M., Alpérovitch, A., & the EUROPARKINSON Study Group (1997) · Neurology · doi:10.1212/wnl.49.5.1267 · Cited by 62 · see citing works
Smoking and Parkinson's disease
Mayeux, R. P., Tang, M., Marder, K. S., COTE, L. J., & Stern, Y. (1994) · Movement Disorders · doi:10.1002/mds.870090215 · Cited by 62 · see citing works
Morens, D. M., Grandinetti, A., Davis, J. W., Ross, G. W., White, L. R., & REED, D. M. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008941 · Cited by 60 · see citing works
Behavioral effects of intrastriatal caffeine mediated by adenosinergic modulation of dopamine
Josselyn, S. A., & Beninger, R. J. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90403-o · Cited by 49 · see citing works
Gray, G. E., Paganini‐Hill, A., Ross, R. K., & Henderson, B. E. (1984) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113775 · Cited by 29 · see citing works
Self-citationPopoli, P., Caporali, M. G., & de Carolis, A. S. (1991) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1991.tb06685.x · Cited by 26 · see citing works
Life-style and Dietary Factors Early and Late in Parkinson’s Disease
Vieregge, P., Maravic, C. V., & Friedrich, H. (1992) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100042219 · Cited by 26 · see citing works
Ascorbic Acid, Redox Cycling, Lipid Peroxidation, and the Binding of Dopamine Receptor Antagonistsa
Heikkila, R. E., & Manzino, L. (1987) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1987.tb23751.x · Cited by 24 · see citing works
Mortality Data for the US for Deaths Due to and Related to Twenty Neurologic Diseases
Chandra, V., Bharucha, N. E., & Schoenberg, B. S. (1985) · Neuroepidemiology · doi:10.1159/000110851 · Cited by 15 · see citing works
Flagged first, then by citations
1 of the 48 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Epidemiology of Parkinson's disease
de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110 · see citing works
Epidemiology and etiology of Parkinson's disease: a review of the evidence
Wirdefeldt, K., Adami, H.-O., Cole, P., Trichopoulos, D., & Mandel, J. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9581-6 · Cited by 1,199 · see citing works
A meta‐analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease
Hernán, M. A., Takkouche, B., Caamaño‐Isorna, F., & Gestal‐Otero, J. J. (2002) · Annals of Neurology · doi:10.1002/ana.10277 · Cited by 818 · see citing works
Parkinson’s Disease: Etiology, Neuropathology, and Pathogenesis
Kouli, A., Torsney, K., & Kuan, W. (2018) · Codon Publications eBooks · doi:10.15586/codonpublications.parkinsonsdisease.2018.ch1 · Cited by 556 · see citing works
E PIDEMIOLOGY OF N EURODEGENERATION
Mayeux, R. P. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.043002.094919 · Cited by 511 · see citing works
Neurodegenerative Diseases: An Overview of Environmental Risk Factors
Brown, R. C., Lockwood, A. H., & Sonawane, B. R. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7567 · Cited by 514 · see citing works
Uversky, V. N. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0937-z · Cited by 312 · see citing works
Association of Body Mass Index and Weight Change with All-Cause Mortality in the Elderly
Corrada, M. M., Kawas, C. H., Mozaffar, F. H., & Paganini‐Hill, A. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj114 · Cited by 291 · see citing works
Self-citationIntake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis
Etminan, M., Gill, S. S., & Samii, A. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70097-1 · Cited by 279 · see citing works
Antioxidants as treatment for neurodegenerative disorders
Moosmann, B., & Behl, C. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.10.1407 · Cited by 253 · see citing works
Costa, J. N., Lunet, N., Santos, C. D., dos Santos, J. P., & Carneiro, A. V. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091525 · Cited by 254 · see citing works
Breckenridge, C. B., Berry, C. L., Chang, E. T., Sielken, R. L., & Mandel, J. S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151841 · Cited by 239 · see citing works
Qi, H., & Li, S. (2013) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12123 · Cited by 234 · see citing works
The association between Mediterranean diet adherence and Parkinson's disease
Alcalay, R. N., Gu, Y., Mejia‐Santana, H., Cote, L., Marder, K. S., & Scarmeas, N. (2012) · Movement Disorders · doi:10.1002/mds.24918 · Cited by 228 · see citing works
Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease
Simon, K. C., Chen, H., Schwarzschild, M. A., & Ascherio, A. (2007) · Neurology · doi:10.1212/01.wnl.0000271883.45010.8a · Cited by 231 · see citing works
Temporal relationship between cigarette smoking and risk of Parkinson disease
Thacker, E. L., O’Reilly, É. J., Weisskopf, M. G., Chen, H., Schwarzschild, M. A., McCullough, M. L., Calle, E. E., Thun, M. J., & Ascherio, A. (2007) · Neurology · doi:10.1212/01.wnl.0000256374.50227.4b · Cited by 193 · see citing works
Dopamine and alcoholism: neurobiological basis of ethanol abuse.
Tupala, E., & Tiihonen, J. (2004) · Progress in Neuro-psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.06.022 · Cited by 209 · see citing works
Tan, E., Tan, C. I. C., Fook-Chong, S. M. C., Lum, S. Y., Chai, A., Chung, H., Shen, H., Zhao, Y., Teoh, M. L., Yih, Y., et al. (2003) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2003.07.006 · Cited by 186 · see citing works
Caffeine and risk of Parkinson’s disease in a large cohort of men and women
Palacios, N., Gao, X., McCullough, M. L., Schwarzschild, M. A., Shah, R., Gapstur, S., & Ascherio, A. (2012) · Movement Disorders · doi:10.1002/mds.25076 · Cited by 185 · see citing works
Prospective study of coffee consumption and risk of Parkinson’s disease
Sääksjärvi, K., Knekt, P., Rissanen, H., Laaksonen, M. A., Reunanen, A., & Männistö, S. (2008) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602788 · Cited by 182 · see citing works
Caffeine Intake, Smoking, and Risk of Parkinson Disease in Men and Women
Liu, R., Guo, X., Park, Y., Huang, X., Sinha, R. R., Freedman, N. D., Hollenbeck, A. R., Blair, A. E., & Chen, H. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kwr451 · Cited by 171 · see citing works
Projection of the prevalence of Parkinson's disease in the coming decades: Revisited
Rossi, A., Berger, K., Chen, H., LESLIE, D. L., Mailman, R. B., & Huang, X. (2017) · Movement Disorders · doi:10.1002/mds.27063 · Cited by 170 · see citing works
Peng, B., Yang, Q., B Joshi, R., Liu, Y., Akbar, M., Song, B.-J., Zhou, S., & Wang, X. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072316 · Cited by 156 · see citing works
Urate: A Novel Biomarker of Parkinson‘s Disease Risk, Diagnosis and Prognosis
Cipriani, S., Chen, X. M., & Schwarzschild, M. A. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.10.94 · Cited by 142 · see citing works
Miyake, Y., Tanaka, K., Fukushima, W., Sasaki, S., Kiyohara, C., Tsuboi, Y., Yamada, T., Oeda, T., Miki, T., Kawamura, N., et al. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.03.002 · Cited by 141 · see citing works
Epidemiology of Parkinson's disease
Kasten, M., Chade, A., & Tanner, C. M. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)83006-5 · Cited by 130 · see citing works
Targeting urate to reduce oxidative stress in Parkinson disease
Crotty, G. F., Ascherio, A., & Schwarzschild, M. A. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.06.017 · Cited by 131 · see citing works
Reduced striatal tyrosine hydroxylase in incidental Lewy body disease
Beach, T. G., Adler, C. H., Sue, L. I., Peirce, J. B., Bachalakuri, J., Dalsing-Hernandez, J. E., Lue, L. F., Caviness, J. N., Connor, D. J., Sabbagh, M. N., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-007-0313-7 · Cited by 128 · see citing works
Dietary antioxidants and risk of Parkinson's disease in two population-based cohorts
Yang, F., Wolk, A., Håkansson, N., Pedersen, N. L., & Wirdefeldt, K. (2017) · Movement Disorders · doi:10.1002/mds.27120 · Cited by 116 · see citing works
Understanding the Links Between Cardiovascular Disease and Parkinson's Disease
Potashkin, J., Huang, X., Becker, C., Chen, H., Foltynie, T., & Marras, C. (2019) · Movement Disorders · doi:10.1002/mds.27836 · Cited by 117 · see citing works
Intake of antioxidant vitamins and risk of Parkinson's disease
Hughes, K. C., Gao, X., Kim, I. Y., Rimm, E. B., Wang, M., Weisskopf, M. G., Schwarzschild, M. A., & Ascherio, A. (2016) · Movement Disorders · doi:10.1002/mds.26819 · Cited by 110 · see citing works
Jee, H. J., Lee, S. G., Bormate, K. J., & Jung, Y.-S. (2020) · Nutrients · doi:10.3390/nu12103080 · Cited by 111 · see citing works
Miyake, Y., Fukushima, W., Tanaka, K., Sasaki, S., Kiyohara, C., Tsuboi, Y., Yamada, T., Oeda, T., Miki, T., Kawamura, N., et al. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03088.x · Cited by 111 · see citing works
Nutritional Risk Factors, Microbiota and Parkinson’s Disease: What Is the Current Evidence?
Boulos, C., Yaghi, N., El Hayeck, R., Heraoui, G. N., & Fakhoury-Sayegh, N. (2019) · Nutrients · doi:10.3390/nu11081896 · Cited by 109 · see citing works
Dietary Factors in the Etiology of Parkinson’s Disease
Ağım, Z. S., & Cannon, J. R. (2015) · BioMed Research International · doi:10.1155/2015/672838 · Cited by 107 · see citing works
Non-alcoholic beverage and caffeine consumption and mortality: The Leisure World Cohort Study
Paganini‐Hill, A., Kawas, C. H., & Corrada, M. M. (2006) · Preventive Medicine · doi:10.1016/j.ypmed.2006.12.011 · Cited by 107 · see citing works
Self-citationNeurobiology of vitamin C: Expanding the focus from antioxidant to endogenous neuromodulator
Ballaz, S., & Rebec, G. V. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104321 · Cited by 106 · see citing works
Cunha, C. D., Angelucci, M. E. M., Canteras, N. S., Wonnacott, S., & Takahashi, R. N. (2002) · Cellular and Molecular Neurobiology · doi:10.1023/a:1020736131907 · Cited by 105 · see citing works
Alcohol intake and risk of Parkinson's disease: A meta‐analysis of observational studies
Zhang, D., Jiang, H. F., & Xie, J. (2014) · Movement Disorders · doi:10.1002/mds.25863 · Cited by 96 · see citing works
Belvisi, D., Pellicciari, R., Fabbrini, G., Tinazzi, M., Berardelli, A., & Defazio, G. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104671 · Cited by 92 · see citing works
Sääksjärvi, K., Knekt, P., Männistö, S., Lyytinen, J., Jääskeläinen, T., Kanerva, N., & Heliövaara, M. (2014) · European Journal of Epidemiology · doi:10.1007/s10654-014-9887-2 · Cited by 88 · see citing works
Alcohol consumption and the incidence of Parkinson's disease
Hernán, M. Á., Chen, H., Schwarzschild, M. A., & Ascherio, A. (2003) · Annals of Neurology · doi:10.1002/ana.10611 · Cited by 87 · see citing works
Vitamin A and Carotenoids and the Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis
Takeda, A., Nyssen, O. P., Syed, A., Jansen, E. H. J. M., Bueno-de-Mesquita, B. H., & Gallo, V. (2013) · Neuroepidemiology · doi:10.1159/000355849 · Cited by 87 · see citing works
Activities and Mortality in the Elderly: The Leisure World Cohort Study
Paganini‐Hill, A., Kawas, C. H., & Corrada, M. M. (2011) · The Journals of Gerontology Series A · doi:10.1093/gerona/glq237 · Cited by 85 · see citing works
Self-citationTea Polyphenols in Parkinson’s Disease
Caruana, M., & Vassallo, N. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-18365-7_6 · Cited by 87 · see citing works
Intake of Japanese and Chinese teas reduces risk of Parkinson’s disease
Tanaka, K., Miyake, Y., Fukushima, W., Sasaki, S., Kiyohara, C., Tsuboi, Y., Yamada, T., Oeda, T., Miki, T., Kawamura, N., et al. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.02.016 · Cited by 76 · see citing works
Alcohol Consumption and Parkinson’s Disease Risk: A Review of Recent Findings
Bettiol, S. S., Rose, T. C., Hughes, C. J., & Smith, L. A. (2015) · Journal of Parkinson s Disease · doi:10.3233/jpd-150533 · Cited by 71 · see citing works
Prospective study on the components of metabolic syndrome and the incidence of Parkinson's disease
Sääksjärvi, K., Knekt, P., Männistö, S., Lyytinen, J., & Heliövaara, M. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.07.017 · Cited by 70 · see citing works
Type of alcohol consumed, changes in intake over time and mortality: the Leisure World Cohort Study
Paganini‐Hill, A., Kawas, C. H., & Corrada, M. M. (2007) · Age and Ageing · doi:10.1093/ageing/afl184 · Cited by 69 · see citing works
Self-citationPrajjwal, P., Sanga, H. S. F., Acharya, K., Tango, T., John, J., Rodriguez, R. S. C., Marsool, M. D. M., Sulaimanov, M., Ahmed, A., & Hussin, O. A. (2023) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000001142 · Cited by 70 · see citing works
Mitochondrial toxins and neurodegenerative diseases
Ayala, A. (2006) · Frontiers in bioscience · doi:10.2741/2119 · Cited by 68 · see citing works
Alcohol and risk of Parkinson's disease in a large, prospective cohort of men and women
Palacios, N., Gao, X., O’Reilly, É. J., Schwarzschild, M. A., McCullough, M. L., Mayo, T. L., Gapstur, S. M., & Ascherio, A. (2012) · Movement Disorders · doi:10.1002/mds.25050 · Cited by 63 · see citing works
Parkinson's Disease and Tea: A Quantitative Review
Quintana, J. L. B., Allam, M. F., del Castillo, A. S., & Navajas, R. F. (2009) · Journal of the American College of Nutrition · doi:10.1080/07315724.2009.10719754 · Cited by 61 · see citing works
Alcohol consumption and risk for Parkinson’s disease: a systematic review and meta-analysis
Jiménez‐Jiménez, F. J., Alonso‐Navarro, H., García‐Martín, E., & Agúndez, J. A. G. (2018) · Journal of Neurology · doi:10.1007/s00415-018-9032-3 · Cited by 60 · see citing works
A Meta-Analysis of Tea Drinking and Risk of Parkinson's Disease
Li, F.-J., Ji, H., & Shen, L. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/923464 · Cited by 57 · see citing works
Gillette, J. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(03)00326-0 · Cited by 57 · see citing works
Behl, T., Madaan, P., Sehgal, A., Singh, S., Sharma, N., Bhatia, S., Al‐Harrasi, A., Chigurupati, S., Alrashdi, I., & BUNGAU, S. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810161 · Cited by 56 · see citing works
The role of nutrition on Parkinson’s disease: a systematic review
Bianchi, V. E., Rizzi, L., & Somaa, F. A. (2022) · Nutritional Neuroscience · doi:10.1080/1028415x.2022.2073107 · Cited by 57 · see citing works
Parkinson's Disease: Risk Factor Modification and Prevention
Rajan, S. M., & Kaas, B. M. (2022) · Seminars in Neurology · doi:10.1055/s-0042-1758780 · Cited by 55 · see citing works
Role and Mechanism of Vitamin A Metabolism in the Pathophysiology of Parkinson’s Disease
Marie, A., Darricau, M., Touyarot, K., Parr‐Brownlie, L. C., & Bosch‐Bouju, C. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212671 · Cited by 54 · see citing works
Talebi, S., Ghoreishy, S. M., Jayedi, A., Travica, N., & Mohammadi, H. (2022) · Advances in Nutrition · doi:10.1093/advances/nmac001 · Cited by 51 · see citing works
Calcium channel blockers and β-blockers in relation to Parkinson's disease
Ton, T. G. N., Heckbert, S. R., Longstreth, W. T., Rossing, M. A., Kukull, W. A., Franklin, G. M., Swanson, P. D., Smith‐Weller, T., & Checkoway, H. (2006) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2006.08.011 · Cited by 51 · see citing works
Reduced Risk of Parkinson’s Disease in Users of Calcium Channel Blockers: A Meta-Analysis
Gudala, K., Kanukula, R., & Bansal, D. (2015) · International Journal of Chronic Diseases · doi:10.1155/2015/697404 · Cited by 48 · see citing works
Schepici, G., Silvestro, S., Bramanti, P., & Mazzon, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134766 · Cited by 47 · see citing works
A systematic review of nutritional risk factors of Parkinson's disease
Ishihara, L., & Brayne, C. (2005) · Nutrition Research Reviews · doi:10.1079/nrr2005108 · Cited by 45 · see citing works
The Epidemiology of Parkinson's Disease
Chen, S.-Y., & Tsai, S. (2010) · Tzu Chi Medical Journal · doi:10.1016/s1016-3190(10)60044-4 · Cited by 44 · see citing works
Cognitive and Neuropsychiatric Features of Early Parkinson's Disease
Getz, S. J., & Levin, B. E. (2017) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acx091 · Cited by 44 · see citing works
The Impact of Coffee and Caffeine on Multiple Sclerosis Compared to Other Neurodegenerative Diseases
Herden, L., & Weissert, R. (2018) · Frontiers in Nutrition · doi:10.3389/fnut.2018.00133 · Cited by 43 · see citing works
Paganini‐Hill, A., Corrada, M. M., & Kawas, C. H. (2006) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000172880.40831.3b · Cited by 42 · see citing works
Self-citationEffect of dietary vitamins C and E on the risk of Parkinson's disease: A meta-analysis
Chang, M. C., Kwak, S. G., & Kwak, S. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.05.011 · Cited by 38 · see citing works
Life style and Parkinson’s disease
Reichmann, H., Csóti, I., Koschel, J., Lorenzl, S., Schrader, C., Winkler, J., & Wüllner, U. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02509-1 · Cited by 38 · see citing works
Voluptuary habits and clinical subtypes of Parkinson's disease: The FRAGAMP case–control study
Nicoletti, A. S. Q., Pugliese, P., Nicoletti, G., Arabia, G., Annesi, G., Mari, M. D., Lamberti, P., Grasso, L., Marconi, R., Epifanio, A., et al. (2010) · Movement Disorders · doi:10.1002/mds.23297 · Cited by 38 · see citing works
Louis, E. D., Benito‐León, J., & Bermejo‐Pareja, F. (2009) · Neuroepidemiology · doi:10.1159/000235641 · Cited by 38 · see citing works
Cardiovascular risk factors and Parkinson's disease in 500,000 Chinese adults
Kizza, J., Lewington, S., Mappin‐Kasirer, B., Turnbull, I. J., Yu, C., Bian, Z., Chen, Y., Yang, L., Chen, Z., Clarke, R., et al. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.732 · Cited by 37 · see citing works
Calcium channel blocker use and risk of Parkinson's disease: a meta-analysis
Lang, Y., Gong, D., & Fan, Y. (2015) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3781 · Cited by 37 · see citing works
Poly, T. N., Islam, M. M., Walther, B. A., Yang, H., Nguyen, P.-A., Huang, C., Syed-Abdul, S., & Li, Y. (2017) · Neuroepidemiology · doi:10.1159/000480401 · Cited by 34 · see citing works
Caffeine and Activation Theory
(2006) · CRC Press eBooks · doi:10.1201/9781420006568 · Cited by 33 · see citing works
Kenborg, L., Lassen, C. F., Ritz, B. R., Andersen, K. K., Christensen, J., Schernhammer, E. S., Hansen, J., Wermuth, L., Rod, N. H., & Olsen, J. H. (2015) · American Journal of Epidemiology · doi:10.1093/aje/kwu332 · Cited by 32 · see citing works
Dietary Antioxidants and Risk of Parkinson's Disease in the Singapore Chinese Health Study
Ying, A. F., Khan, S., Wu, Y., Jin, A., Wong, A. S. Y., Tan, E., Yuan, J., Koh, W., & Tan, L. (2020) · Movement Disorders · doi:10.1002/mds.28173 · Cited by 32 · see citing works
The role of environmental agents in Parkinson's disease
Monte, D. A. D. (2001) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(01)00020-2 · Cited by 32 · see citing works
Paganini‐Hill, A. (2011) · Cardiology Research and Practice · doi:10.4061/2011/983764 · Cited by 31 · see citing works
Self-citationAcetaldehyde and parkinsonism: role of CYP450 2E1
Vaglini, F., Viaggi, C., Valentina, P., Pardini, C., Gerace, C., Scarselli, M., & Corsini, G. U. (2013) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00071 · Cited by 31 · see citing works
Case-control study of hypertension and Parkinson’s disease
Ng, Y.-F., Ng, E., Lim, E., Prakash, K. M., Tan, L. C. S., & Tan, E. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00202-w · Cited by 30 · see citing works
Antioxidant Vitamin Intake and Mortality
Paganini‐Hill, A., Kawas, C. H., & Corrada, M. M. (2014) · American Journal of Epidemiology · doi:10.1093/aje/kwu294 · Cited by 29 · see citing works
Self-citationAlcohol and Parkinson’s Disease: A Systematic Review and Meta-Analysis
Mitchell, E., Chohan, H., Bestwick, J. P., & Noyce, A. J. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223522 · Cited by 29 · see citing works
Conroy, S. K., Brownlowe, K. B., & McAllister, T. W. (2020) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20200004 · Cited by 29 · see citing works
Parkinson's disease: the nutrition perspective
Breasail, M. Ó., Smith, M. D., Tenison, E., Henderson, E. J., & Lithander, F. E. (2021) · Proceedings of The Nutrition Society · doi:10.1017/s0029665121003645 · Cited by 27 · see citing works
Recent research progress on metabolic syndrome and risk of Parkinson’s disease
Li, L., Liu, S., Zhuang, J.-L., Li, M.-M., Huang, Z., Chen, Y., Chen, X., Chen, C., Lin, S., & Ye, L. (2022) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0093 · Cited by 27 · see citing works
Shao, C., Wang, X., Wang, P., Tang, H., He, J., & Wu, N. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.709846 · Cited by 26 · see citing works
Jain, S., Himali, J. J., Beiser, A., Ton, T. G. N., Kelly‐Hayes, M., Biggs, M. L., Delaney, J. A., Rosano, C., Seshadri, S. S., & Frank, S. (2014) · American Journal of Epidemiology · doi:10.1093/aje/kwu326 · Cited by 25 · see citing works
Rees, K., Stowe, R. L., Patel, S., Ives, N. J., Breen, K. C., Ben‐Shlomo, Y., & Clarke, C. E. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008535.pub2 · Cited by 25 · see citing works
Bagatini, P. B., Saur, L., Rodrigues, M. F., Bernardino, G. C., Paim, M. F., Coelho, G. P., da Silva, D. V., de Oliveira, R. M., Schirmer, H., Souto, A. A., et al. (2011) · Invertebrate Neuroscience · doi:10.1007/s10158-011-0116-3 · Cited by 24 · see citing works
Mazza, A., Ravenni, R., Antonini, A., Casiglia, E., Rubello, D., & Pauletto, P. (2012) · Neurological Sciences · doi:10.1007/s10072-012-1251-2 · Cited by 23 · see citing works
Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson’s disease
Thaler, A., Shenhar‐Tsarfaty, S., Shaked, Y., Gurevich, T., Omer, N., Bar‐Shira, A., Gana‐Weisz, M., Goldstein, O., Kestenbaum, M., Cedarbaum, J. M., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-66319-9 · Cited by 22 · see citing works
Chan, D. K. Y., Cordato, D. J., Bui, T., Mellick, G. D., & Woo, J. (2004) · Neuroepidemiology · doi:10.1159/000073970 · Cited by 20 · see citing works
Niu, F., Xie, W., Zhang, W., Kawuki, J., & Yu, X. (2023) · Nutritional Neuroscience · doi:10.1080/1028415x.2023.2192561 · Cited by 19 · see citing works
The role of α-synuclein in the pathophysiology of alcoholism
Janeczek, P., & Lewohl, J. M. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.06.007 · Cited by 19 · see citing works
Alcohol Intake and Parkinson's Disease Risk in the Million Women Study
Kim, I. Y., Yang, T. O., Heath, A. K., Simpson, R. F., REEVES, G. K., Green, J., Floud, S., Brown, A., Hunter, D. J., Beral, V., et al. (2019) · Movement Disorders · doi:10.1002/mds.27933 · Cited by 18 · see citing works
Effects of cigarettes and alcohol consumption in benign paroxysmal positioning vertigo
Sunami, K., Tochino, R., Tokuhara, Y., Yamamoto, H., Tomita, S., Koshimo, N., & Yamane, H. (2006) · Acta Oto-Laryngologica · doi:10.1080/00016480500527474 · Cited by 18 · see citing works
Rajput, A. H., Rajput, A. H., & Rajput, M. L. (2003) · CRC Press eBooks · doi:10.1201/9780203912164-6 · Cited by 17 · see citing works
- Authors
- Paganini-Hill, A.
- Venue
- Neuroepidemiology
- Publisher
- S. Karger AG
- Published
- 2001
- Volume
- 20
- Issue
- 2
- Pages
- 118-124
- ISSN
- 0251-5350 (ISSN-L)
- 1423-0208
- OpenAlex
- W2025540146
- Cited by
- 159
- References
- 48
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 4 · 2023: 5 · 2022: 12 · 2021: 10 · 2020: 6 · 2019: 6 · 2018: 8 · 2017: 7 · 2016: 5 · 2015: 9 · 2014: 8 · 2013: 4 · 2012: 7
- FWCI
- 4.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuroepidemiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R01CA032197, CA32197)
- Topics
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nuclear Receptors and Signaling
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Parkinson's disease, risk factors, smoking, hypertension, coffee consumption, alcohol consumption, number of children, vitamin A intake, vitamin C intake, multifactorial etiology, environmental risk factors, retirement community residents
- MeSH terms
- Adult, Aged, Aged, 80 and over, Alcoholism, Ascorbic Acid, Caffeine, California, Catchment Area, Health, Female, Humans, Hypertension, Male, Middle Aged, Parkinson Disease, Prospective Studies, Risk Factors, Smoking, Vitamin A, Cohort Studies, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
